A324039 Recombinant human monoclonal antibody to GLP-1R for ELISA, FACS, Functional Assay and In Vivo
For an 80 mg vial reconstituted with 3.0 mL of bacteriostatic water, the standard published research dose is ~2.67 mg per day, equal to 10 units on a U-100 insulin syringe (0.10 mL)
However, studies using recombinant human IGF-1 (rhIGF-1), the native hormone that IGF-1 LR3 mimics more potently, provide the closest human evidence
Overall, the current body of research indicates that SFN could serve as a beneficial complementary treatment for ASD
Ensuring you have the right medication involves checking the packaging, consulting with your pharmacist, and using reliable resources for confirmation